Home > Specialists > Hematology > Dr. Miao Chen (陈苗)
Specialty & Clinical Focus:
Chief Physician and hematology specialist at Peking Union Medical College Hospital in Beijing, with a clinical focus on aplastic anemia, porphyria, hemolytic anemia, myelodysplastic syndromes, platelet disorders, and complex red blood cell diseases.
Professional Title & Qualifications:
-
Chief Physician
-
Professor & Master's Supervisor
-
M.D., Peking Union Medical College
Hospital & Department：
Peking Union Medical College Hospital (PUMCH) – Department of Hematology
(address: No. 1 Shuaifuyuan, Dongdan, Dongcheng District, Beijing, 100730)
Dr. Miao Chen (陈苗) - Renowned Hematologist
Personal Biography
Dr. Miao Chen is a Chief Physician, Professor, and Master's Supervisor in the Department of Hematology at Peking Union Medical College Hospital (PUMCH) in Beijing. She earned her M.D. from the eight-year clinical medicine program at Peking Union Medical College in 2004 and has worked in the PUMCH Department of Hematology since then.
Her clinical focus includes anemia and platelet disorders, particularly aplastic anemia, porphyria, hemolytic anemia, myelodysplastic syndromes, and complex red blood cell diseases. Dr. Chen also contributes to multidisciplinary care for complex cases and to research and expert consensus development in rare hematologic disorders.
Why Choose Dr. Miao Chen for Hematology Care in China?
Dr. Miao Chen’s long-standing hematology practice at PUMCH and her focus on complex anemia, platelet disorders, and rare blood diseases make her a relevant specialist for international patients seeking an expert review before deciding whether to travel to Beijing. A well-prepared case file—including recent laboratory results, relevant bone marrow or pathology reports, previous treatment history, and a focused question list—helps Dr. Chen assess the clinical context efficiently and provide an informed opinion on possible next steps.
Pre-Travel Case Review & Specialist Liaison
Before committing to medical travel to China, MedBridgeNZ can coordinate a structured pre-travel case-review pathway with Dr. Miao Chen and the relevant PUMCH office. We help organize your medical records, coordinate translation where required, and securely transfer client-authorized documents for specialist review.
Once MedBridgeNZ confirms the coordinated review pathway and the required case file is complete, the relevant hospital specialist will review the submitted materials, provide a medical opinion and recommendations, and respond to the questions included in your case file. MedBridgeNZ can then coordinate appointment communication and practical travel planning, including medical invitation or visa-document support, bilingual administrative assistance, and related logistics for an in-person pathway in Beijing.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Miao Chen
Areas of Expertise
Aplastic Anemia (AA): Expert management of bone marrow failure syndromes, utilizing intensive immunosuppressive therapy and optimized drug combinations for refractory cases.
Rare Hematologic Diseases: Leading specialist for Porphyria and Hemochromatosis, managing dedicated clinical cohorts for these rare conditions.
Hemolytic Anemia: Precision typing and targeted therapies for Autoimmune Hemolytic Anemia (AIHA) and Paroxysmal Nocturnal Hemoglobinuria (PNH).
Myelodysplastic Syndromes (MDS): Comprehensive diagnosis and treatment of MDS and associated complications.
Red Blood Cell Disorders: Advanced solutions for complex and undiagnosed anemias.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
7,900 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
August 2004 – Present: Department of Hematology, Peking Union Medical College Hospital (PUMCH), Beijing.
Roles held: Resident Physician, Attending Physician, Associate Chief Physician, Chief Physician.
Education & Training
2004: M.D., 8-year clinical medicine program, Peking Union Medical College.
Awards & Honors
2023: University-level Excellent Communist Party Member
2021: Hospital-level Excellent Communist Party Member
2019: Hospital-level Excellent Employee
2014: University-level Excellent Communist Party Member
2014: Outstanding Ward Attending Physician (Internal Medicine)
Beijing High School High-Quality Undergraduate Lesson Plan Award (Beijing Municipal Education Commission)
Third Prize, PUMCH Teachers' Teaching Innovation Competition (Curriculum Ideological and Political Group)
Third Prize, PUMCH Young Teachers' Basic Skills Competition
Academic & Professional Memberships
Member, Red Blood Cell Disease Group, Hematology Branch of the Chinese Medical Association
Committee Member, Hematology Branch of the Chinese Geriatrics Society
Committee Member, Targeted Therapy Professional Committee of the China Women Doctors Association
Vice Chairman, Porphyria Professional Committee of the China Alliance for Rare Diseases / Beijing Rare Disease Diagnosis and Protection Society
Committee Member, Hematology Professional Committee of the Beijing Perioperative Medicine Research Society
Committee Member, Red Blood Cell Disease Committee of the Hematology Working Committee, Beijing Cancer Prevention Society
Member, Multidisciplinary Team (MDT) Expert Group, China Alliance for Rare Diseases
Expert, National Health Professional and Technical Qualification Examination Question Bank Construction (National Health Commission)
Review Expert, Beijing Municipal Science and Technology Commission Projects
Young Editorial Board Member, Journal of Rare Diseases
Research & Publications
Publications: Published over 70 papers in core domestic and international journals.
Guideline Formulation: Lead author or contributor to multiple expert consensuses, including:
Chinese Expert Consensus on the Diagnosis and Treatment of Porphyria (2020)
Expert Consensus on Multidisciplinary Diagnosis and Treatment of Gaucher Disease (2020)
Chinese Expert Consensus on the Diagnosis and Treatment of Fanconi Anemia (2022)
Expert Consensus on Multidisciplinary Diagnosis and Treatment of Paroxysmal Nocturnal Hemoglobinuria (2024)
Expert Consensus on TPO Receptor Agonist Treatment for Aplastic Anemia
Book Editorship:
Vice-Editor, Collection of Difficult Red Blood Cell Cases (2019)
Editorial Board Member, Hemolytic Anemia digital course for "Internal Medicine" (2nd Edition, 2023)
Translations: Participated in translating Williams Hematology, Cecil Medicine, and First Aid for the USMLE Step 1.
Research Projects: Hosted and participated in projects funded by the National Natural Science Foundation of China, the Central High-Level Hospital Clinical Research Special Fund, and the China Cancer Foundation.
Selected Peer-Reviewed Publications
Zhao X, Sun J, Zhang Z, Chen M, et al. Sovleplenib in patients with primary or secondary warm autoimmune haemolytic anaemia: results from phase 2 of a randomised, double-blind, placebo-controlled, phase 2/3 study. Lancet Haematol. 2025;12(2):e97–e108. PMID: 39799953.
Ji J, Wan Z, Ruan J, Yang Y, et al. Eltrombopag with or without tacrolimus for relapsed/refractory acquired aplastic anaemia: a prospective randomized trial. Blood Cancer J. 2023;13(1):146. PMID: 37726286.
Wang Q, Zhuang JL, Han B, Chen M, et al. Drug-associated porphyria: a pharmacovigilance study. Orphanet J Rare Dis. 2024;19(1):286. PMID: 39090656.
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Is Dr. Miao Chen the right hematology specialist for my condition?
Dr. Chen’s stated clinical focus includes aplastic anemia, porphyria, hemolytic anemia, myelodysplastic syndromes, platelet disorders, and other complex red blood cell diseases. To explore whether your case falls within this scope, MedBridgeNZ can coordinate a remote specialist-review request and help prepare, translate, and securely transfer your medical records with your authorization. Once MedBridgeNZ confirms the review pathway and the case file is complete, Dr. Chen or the relevant PUMCH specialist team will review the materials, provide an opinion and recommendations, and address the questions submitted with your case.
How can I request a remote specialist review with Dr. Chen at PUMCH?
Start by providing MedBridgeNZ with a brief case summary, recent test results, relevant reports, previous treatment history, and the questions you would like the specialist to address. Our team coordinates record organization, translation, client-authorized document transfer, and communication with the relevant PUMCH office. After the hospital specialist reviews the completed case file, MedBridgeNZ coordinates delivery of the specialist feedback and can assist with appointment communication if you decide to explore an in-person visit to Beijing.
What support is available if I decide to travel to Beijing for in-person care?
If you decide to pursue an in-person pathway after the specialist review, MedBridgeNZ can coordinate the practical next steps. Support may include hospital appointment communication, medical invitation or visa-document coordination, travel and accommodation planning, translation coordination, and non-clinical bilingual administrative assistance during hospital visits. The arrangements are tailored to the confirmed hospital pathway, your travel dates, and the level of coordination you request, helping you move from remote case review to an organized medical journey in China.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients exploring specialist-care pathways in China. We coordinate appointment requests, medical-record preparation, translation, client-authorized document transfer, medical invitation or visa-document support, travel planning, and non-clinical bilingual administrative assistance. Our role is to make the administrative journey clearer and better organized from initial specialist review through travel. MedBridgeNZ does not provide medical advice, diagnosis or treatment. Hospital, specialist, and other third-party medical or travel charges are separate from MedBridgeNZ coordination fees unless expressly stated in writing.